ScholarLens Back to search
2005•Unpublished venueRequires access

Piperacillin/tazobactam on Hospital Acquired Pneumonia

Shu Li-hua

Open publisher page 0 citations

Abstract

OBJECTIVE To evaluate the clinical efficacy of piperacillin/tazobactam for hospital acquired pneumonia. METHODS Totally 158 cases of hospital acquired pneumonia were randomized into piperacillin/tazobactam group and ceftazidime group, and sputum culture was underwent for each case before and after treatment. RESULTS The total efficacy rates and bacterial clearance rates in piperacillin/tazobactam group and ceftazidime group were (89.74%) and (61.25%,) (88.89%) and (58.70%,) respectively, and the differences between the two groups were statistically significant. CONCLUSIONS It suggested that piperacillin/tazobactam be a more effective drug for hospital acquired pneumonia.

About this research paper

What this paper is about

OBJECTIVE To evaluate the clinical efficacy of piperacillin/tazobactam for hospital acquired pneumonia. METHODS Totally 158 cases of hospital acquired pneumonia were randomized into piperacillin/tazobactam group and ceftazidime group, and sputum culture was underwent for each case before and after treatment. RESULTS The total efficacy rates and bacterial clearance rates in piperacillin/tazobactam group and ceftazidime group were (89.74%) and (61.25%,) (88.89%) and (58.70%,) respectively, and the differences between the two groups were statistically significant. CONCLUSIONS It suggested that piperacillin/tazobactam be a more effective drug for hospital acquired pneumonia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To evaluate the clinical efficacy of piperacillin/tazobactam for hospital acquired pneumonia. METHODS Totally 158 cases of hospital acquired pneumonia were randomized into piperacillin/tazobactam group and ceftazidime group, and sputum culture was underwent for each case before and after treatment. RESULTS The total efficacy rates and bacterial clearance rates in piperacillin/tazobactam group and ceftazidime group were (89.74%) and (61.25%,) (88.89%) and (58.70%,) respectively, and the differences between the two groups were statistically significant. CONCLUSIONS It suggested that piperacillin/tazobactam be a more effective drug for hospital acquired pneumonia.

Key concepts: Piperacillin/tazobactam, Piperacillin, Tazobactam, Medicine, Ceftazidime, Pneumonia, Hospital-acquired pneumonia, Sputum

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Piperacillin/tazobactam on Hospital Acquired Pneumonia — Research Paper | ScholarLens